As per statistics provided by the World Health Organization (WHO), about half of the world population is at risk of malaria. This has resulted in an increased preference of various healthcare agencies towards addressing this major problem. The other non-profit organizations such as the Melinda Gates Foundation and PATH are working towards the development of preventive measures as well as saving various lives in the malaria hit regions. The largest number of malaria cases are registered in Africa and therefore, this region is the major target of launching the novel malaria vaccine developed by GlaxoSmithKline plc. The European approval was granted to Mosquirix in 2015 and is currently being examined in Africa as a pilot study.
Market Outlook:
The African people utilize insecticide-treated mosquito nets as well as indoor-insecticide spraying for protection against malarial vectors. In Africa, the usage of insecticide-treated mosquito nets increased by 80% during the period of 2010-2015. Also, large number of mosquito repellent products such as coils, patches, mats, creams, liquids and others are marketed across the globe. The non-profit organizations are also engaged in providing cheap and free treatment facilities to the people suffering from malaria in Africa. Also, GSK has thought of selling the vaccines at lower cost forgoing its huge profit margins in order to support the worldwide malaria eradication programs. Further, owing to the presence of more malarial vaccines under research pipeline, the malaria vaccines market is expected to grow in future
Request For Free Sample Of The Report @ http://bit.ly/2JZk9lv_Malaria_Vaccines_Market
Factors promoting the growth of malaria vaccines market include high demand for vaccines for important diseases owing to rising focus on biological preparations. Also, various governments across several countries as well as companies, and non-profit organizations are contributing towards preventing the spread of this disease. The governments across various regions are majorly involved in programs targeted at curbing malaria. For instance, WHO had withdrawn funding for pilot program in first phase during 2017 and 2020 by the global fund to combat against malaria and other disease such as AIDS and tuberculosis that are prevalent across the globe.
Major players:
GlaxoSmithKline Plc
Sanaria Inc
Sumaya Biotech
GenVec Inc
Nobelpharma Co.
In 2015, WHO established a global technical strategy for malaria 2016-2030 with some defined goals. One of the major goals aimed at curbing malaria in at least 10 countries. The Indian government has recognized certain Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for offering ease of access to anti-malarial drugs. Various government programs are being regularly monitored and are under surveillance to reduce malarial cases. This kind of support from these national as well as global initiatives will fuel the malaria vaccines market growth during the future period.
Obtain Details @ https://www.xpodenceresearch.com/Reports/Malaria-Vaccines--Market
Based on regions, the global malaria vaccines market is divided into North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA), and Latin America. The North American region is anticipated to command the maximum market share and would lead the malaria vaccines market during the forecast period. However, the Asia-Pacific and Middle-Eastern regions is anticipated to register swift growth during the forecast period owing to the large patient population.
If you have any special requirements, please let us know and we will offer you the report as you want.
About Us
Xpodence Research is a U.S. based Market Research Company and offers the most extensive collection of progressive surveying syndicated and customized research reports of various categories for private and public industries across the globe.
We offer the comprehensive market research solution for all the industries by performing the in-depth study of industry trends, verticals globally. We believe in building an eternal bond with our customers through providing them inclusive research study both customized and syndicated based on their specific requirements.
The organizations in every industry such as Technology, Pharmaceuticals, Consumable Goods, Food & Beverage and others demands a market-based solutions for various significant decisions based on productivity and output globally. Our services are tailored specifically to our clients by proposing them the potential outcome, based on our in-depth analysis and insights for exploring the growth strategies through providing the best possible decision for quality production.
Contact Us
244 , Madison Avenue
New York City, NY - 10016
United States
E-mail: sales@xpodenceresearch.com